Press release
Rising Prevalence Of Alzheimer's Disease Fuels Growth In The Alzheimer's Disease Treatment Market: Major Factor in the Transformation of the Alzheimer's Disease Treatment Market in 2025
Alzheimer's Disease Treatment Global Market Report 2025
The market for Alzheimer's disease treatment has seen robust growth in the recent past. It is projected to increase from a value of $5.93 billion in 2024 to $6.41 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. The significant growth during the recent period can be attributed to factors such as advancements in research and understanding of the disease, the approval and introduction of new drugs, initiatives and funding from the government, and increased awareness and education among the public.
The market size for treatment of Alzheimer's disease is anticipated to witness substantial growth in the coming years. With a compound annual growth rate (CAGR) of 6.8%, it is predicted to reach $8.35 billion by 2029. The projected growth during this period can be attributed to factors such as the implementation of precision medicine strategies, an increase in healthcare spending, the worldwide disease burden, research in genetics and biomarkers, and emerging markets. Significant trends expected during this period include breakthroughs in biotechnology, technological advancements, the development of digital health technologies, neuroinflammation modulation strategies, as well as collaborations and partnerships.
What Key Elements Are Boosting Growth in the Alzheimer's Disease Treatment Market?
The surge in Alzheimer's cases is significantly influencing the expansion of the market for Alzheimer's disease treatment. Alzheimer's, the most prevalent kind of dementia, is anticipated to grow in every US state by a minimum of 14% by 2025, as projected by the USA Alzheimer's Association. This is mainly due to the escalating geriatric population. On a worldwide scale, anticipated new Alzheimer's cases are projected to rise by 35% to 615,000 by 2030, and by 110% to 959,000 by 2050. Hence, the escalating incidence of Alzheimer's disease is presumed to fuel the demand for the global Alzheimer's disease treatment market's growth.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3409&type=smp
Who Are the Major Industry Players Fueling Alzheimer's Disease Treatment Market Expansion?
Major companies operating in the alzheimer's disease treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Merck Sharp & Dohme Corp., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., UCB S.A., Eisai Co. Ltd., Forest Laboratories LLC, Ono Pharmaceutical Co. Ltd., H. Lundbeck A/S, Allergan plc, Luye Pharma Group, Avanir Pharmaceuticals Inc., Denali Therapeutics Inc., Athira Pharma Inc., ProMIS Neurosciences Inc., AC Immune SA, vTv Therapeutics Inc., AB Science SA, TauRx Pharmaceuticals Ltd., Alzheon Inc.
Which Key Developments Are Influencing the Alzheimer's Disease Treatment Market?
Top firms in the Alzheimer's disease treatment market are seeking regulatory approvals as part of their strategy to achieve a competitive advantage and broaden their product range. Such approvals are formal permissions provided by government bodies like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), permitting a product to be marketed and sold. For example, in July 2024, the US pharmaceutical firm, Eli Lilly and Company, secured FDA approval for their Alzheimer's drug, Kisunla (donanemab-azbt). This drug, aimed at adults with early symptomatic Alzheimer's disease including those with mild cognitive impairment and mild dementia, is given monthly via an intravenous infusion and, according to clinical trials, slows disease progression. The authorization highlights its potential significance, as it has already received Fast Track, Priority Review, and Breakthrough Therapy status.
How Is the Segmentation of the Alzheimer's Disease Treatment Market Defined?
The alzheimer's disease treatment market covered in this report is segmented -
1) By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins
2) By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists
3) By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics
Subsegments:
1) By Cholinergic: Donepezil, Galantamine, Rivastigmine
2) By Memantine: Memantine Hydrochloride, Extended-Release Memantine
3) By Combined Drug: Donepezil and Memantine Combination
4) By AChE Inhibitors: Tacrine, Physical Inhibitors
5) By Immunoglobulins: IVIG (Intravenous Immunoglobulin), Monoclonal Antibodies
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report
What Is the Leading Region in the Alzheimer's Disease Treatment Market?
The countries covered in the Alzheimer's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
What Is Covered In The Alzheimer's Disease Treatment Global Market Report?
- Market Size Analysis: Analyze the Alzheimer's Disease Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Alzheimer's Disease Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Alzheimer's Disease Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Alzheimer's Disease Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3409
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Alzheimer's Disease Fuels Growth In The Alzheimer's Disease Treatment Market: Major Factor in the Transformation of the Alzheimer's Disease Treatment Market in 2025 here
News-ID: 3931754 • Views: …
More Releases from The Business Research Company
Outlook for the Ready To Drink (RTD) Alcoholic Beverages Market: Major Segments, …
The ready-to-drink (RTD) alcoholic beverages market is on track to experience significant growth over the coming years, driven by evolving consumer preferences and industry innovations. This sector is rapidly expanding as more consumers seek premium, convenient, and sustainable options in their alcoholic beverage choices. Let's explore the market's projected size, key drivers, major players, emerging trends, and segmentation details shaping its future.
Projected Expansion and Market Size of the Ready To…
Emerging Sub-Segments Transforming the Pumpkin Seed Protein Market Landscape
The pumpkin seed protein market is emerging as a promising sector within the broader landscape of plant-based proteins. With increasing consumer interest in alternative, allergen-free protein sources and sustainable nutrition, this market is set to witness substantial growth and innovation. Let's explore the market size projections, key players, current trends, and major product segments shaping the future of pumpkin seed protein.
Projected Market Valuation and Growth Expectations for Pumpkin Seed Protein…
Top Players and Market Competition in the Protein Hydrolysates Industry
The protein hydrolysates market is positioned for significant expansion in the coming years as consumer preferences and nutritional science continue to evolve. With increasing attention on tailored nutrition solutions and the rise of plant-based options, this market is gearing up for robust growth and innovation.
Protein Hydrolysates Market Size Projections Through 2030
The protein hydrolysates market is forecasted to grow substantially, reaching a value of $7.25 billion by 2030. This…
Processed Meat Market Overview: Major Segments, Strategic Developments, and Lead …
The processed meat industry is positioned for substantial expansion over the coming years, driven by evolving consumer preferences and technological advancements. As the market adapts to changing demands and regulatory landscapes, it is expected to reach impressive valuation milestones. Let's explore the current market size, key players, emerging trends, and detailed segment analyses shaping this sector's future.
Forecasted Market Size and Growth Trajectory of the Processed Meat Market
The processed…
More Releases for Alzheimer
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928
Key Takeaways
• Disease-modifying…
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
